Status:
UNKNOWN
Effects of COVID 19 Vaccine on Egyptian Population
Lead Sponsor:
Assiut University
Conditions:
COVID 19 Vaccine
Eligibility:
All Genders
18-80 years
Brief Summary
The aim of this study is to identify adverse events following vaccination by the COVID-19 vaccine by evaluating adverse side effects, hematological values; immunogenicity in the Egyptian candidates in...
Detailed Description
Coronavirus disease 2019 (COVID-19) is an emerging respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that had infected more than 100 million individ...
Eligibility Criteria
Inclusion
- People aged 18-80 years.
- Negative for serum-specific IgM/IgG antibodies against SARS-CoV-2, as measured by a commercial kit (Innovita, China) at the time of screening.
Exclusion
- A history of infection with SARS-CoV 3 months before the vaccine.
- Fever, cough, runny nose, sore throat, diarrhoea, dyspnoea, or tachypnoea in the 14 days before vaccination.
- Pregnancy.
- A history of seizures or mental illness.
- Being on immunosuppressive agents.
- Being on anticoagulation therapy.
- Being unable to comply with the study schedule.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04809948
Start Date
March 1 2021
End Date
December 30 2021
Last Update
March 24 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.